Treating Anhedonia in Depression:
Why the Reward System Is the Key Target — and What VR Reward Training Can Do
A patient reports that she did nothing over the weekend — not because she was too exhausted, but because there was simply no impulse. She had known that a walk “would be good.” She didn’t go. Not out of lack of drive, but out of indifference. This distinction is clinically decisive: while reduced drive stems from activation inhibition, anhedonia describes the absence of any affective pull toward action — and targets an entirely different neurobiological mechanism.
Anhedonia is one of the core symptoms of depressive disorders and at the same time the one most frequently underweighted in treatment planning. Part of the reason is that it often hides behind other complaints in clinical conversations: sleep problems, concentration difficulties, fatigue dominate the picture. The loss of pleasure — the actual problem — is rarely named, because patients frequently have no direct access to it. They don’t know that anticipatory joy is missing. They only know they can’t find a reason to start.
Treating Anhedonia: Why Classical Behavioural Activation Fails in Anhedonia
Behavioural activation is one of the best-evidenced psychotherapeutic interventions for depression. Its core principle — deliberately seeking out potentially reinforcing situations despite low motivation — works for most patients. In pronounced anhedonia, however, it runs into a specific limitation.
Current research distinguishes between consummatory and anticipatory anhedonia. Consummatory refers to the inability to experience pleasure in the moment itself. Anticipatory refers to the absence of positive expectation — the lack of any forward-looking positive signal that could function as a motivation for action. In depressive disorders, it is primarily the anticipatory component that is affected. Patients may theoretically be capable of experiencing pleasure, but cannot build any expectation of positive states.
Clinicians know the scenario: the agreed activities are completed — and afterwards comes the sentence “I didn’t feel anything.” The experience doesn’t materialise, the therapeutic rationale loses its persuasive power, compliance drops. Behavioural activation presupposes that anticipation functions as an engine. When precisely that engine has failed, a different entry point is needed.
The Neurobiology of Anhedonia: When the Reward System Stops Predicting
This explains why psychoeducation alone is insufficient: the problem is neurobiological. Anhedonia is associated with a dysfunction of the mesolimbic dopaminergic system — specifically in the prediction phase, not the experience of reward itself. Pizzagalli et al. (2009, American Journal of Psychiatry) demonstrated reduced ventral striatum activation in MDD patients during reward anticipation phases, a finding that has since been replicated in multiple studies. In plain terms: the part of the brain that normally sends the signal “this will be good” — thereby initiating action — is attenuated in anhedonic depression. Not absent, but too quiet to be motivationally relevant.
VR Reward Training in Anhedonia: Direct Access to the Disrupted Reward System
VR-based interventions target precisely this point. Rather than encouraging the patient to seek out real-world rewarding situations, they provide repeated, controlled exposure to positive stimuli — with a degree of immersion that image-based methods cannot achieve. Social scenarios, natural environments, encouraging interactions become experienceable without requiring a prior motivational impulse.
The goal of VR Reward Training is not relaxation or distraction, but the gradual reactivation of the coupling between stimulus perception and positive affective response — at the level where the disorder actually operates.
A key difference from imagination-based methods lies here. Positive imagery exercises require patients to actively construct an inner image — a capacity that is often also impaired in anhedonic depression. VR delivers the positive environment without requiring that cognitive groundwork. Patients do not need to invest inner energy to generate the experience — they are reached by it before internal resistance can set in.
Current Research on VR and Anhedonia Treatment in Depression
A pilot study (Frontiers in Psychology, 2020) examined VR Reward Training in anhedonic symptomatology and reported significant reductions in self-reported anhedonia, depression severity, and functional impairment from baseline to one-month follow-up. The sample was small, the study not randomised controlled — results should be considered preliminary clinical signals, not conclusive evidence. A clinical trial (NCT06178731) is currently underway examining VR Reward Training in combination with transcranial magnetic stimulation in depression.
The evidence base remains limited. What supports clinical use is the neurobiological coherence of the approach: VR Reward Training does not address symptoms indirectly, but targets the mechanism directly.
Treating Anhedonia in Clinical Practice: Indication and Integration
VR Reward Training is not a replacement therapy, but a complementary access point for a specific indication: patients with pronounced anticipatory anhedonia in whom classical behavioural activation has repeatedly failed.
The clinical value lies in two aspects. First, VR offers a low-threshold entry point: the positive experience in the virtual environment functions without any prior motivational impulse — it can serve as lived evidence that positive affective responses are still possible. This shifts the therapeutic rationale: not “you should do something to feel better,” but “you just felt something — let’s work with that.”
Second, VR enables individually tailored exposure without social pressure. Patients who are difficult to reach through group-based activation formats can engage with VR interventions individually, in a calm environment, and at their own pace. Particularly in inpatient psychiatry, where daily structure and group offerings present a real barrier for severely anhedonic patients, this can enable a therapeutic entry point that would otherwise not occur.
In practice, VR Reward Training is not deployed as a standalone intervention but as a preparatory or complementary component: the positive experience in the session is then therapeutically processed — as a starting point for psychoeducation about the reward system, as a basis for discussion about anticipatory anhedonia, as evidence that affective responses remain possible.
What VR Reward Training Cannot Yet Do: Limits of the Approach
Randomised controlled trials with adequate sample sizes are largely absent for this specific application. Questions regarding optimal dosing, session frequency, and patient subgroup differentiation remain open. For which patient subgroups — by severity, comorbidity, or neurobiological profile — the effect is most pronounced is not yet known.
VR Reward Training is a biologically plausible and clinically promising approach. It is not an established standard procedure.
Conclusion
Treating anhedonia means addressing the right mechanism — not forcing motivation through activation, but gradually reactivating the anticipation of positive experiences. VR Reward Training offers a direct, neurobiologically grounded access point that does not replace classical methods but meaningfully complements them — particularly where those methods reach their limits.
For institutions looking to integrate VR-based interventions into existing treatment pathways, the VR Coach smartsystem provides clinically validated scenarios for precisely this indication.
Would you like to learn how the VR Coach® smartsystem can be integrated into your clinic or practice?
We would be happy to provide detailed information, answer your questions, and discuss potential applications in your therapeutic setting — with no obligation.
